Literature DB >> 31274618

Thyroid Incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT Revealing a Medullary Thyroid Carcinoma.

Renaud Ciappuccini1,2, Agathe Edet-Sanson3, Virginie Saguet-Rysanek4, Mathieu Gauthé5, Stéphane Bardet1.   

Abstract

A 66-year-old man with prostate cancer underwent F-fluorocholine PET/CT and thereafter Ga-labeled prostate-specific membrane antigen PET/CT to explore a rising prostate-specific antigen level. Both PET/CT studies showed a thyroid incidentaloma of the right lobe. Neck ultrasound confirmed the presence of a 16-mm right thyroid nodule. The serum calcitonin level was moderately increased at 25 ng/mL (<10). Cytology was non-diagnostic (Bethesda I). A right lobectomy was performed and pathology revealed a 15-mm medullary thyroid cancer. Two months after surgery, the calcitonin level returned to normal at 3.3 ng/mL.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31274618     DOI： 10.1097/RLU.0000000000002559

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  8 in total

1.  Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center.

Authors:  Marceline W Piek; Lisa H de Vries; Maarten L Donswijk; Bart de Keizer; Jan Paul de Boer; Lutske Lodewijk; Rachel S van Leeuwaarde; Menno R Vriens; Koen J Hartemink; Iris M C van der Ploeg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-15       Impact factor: 10.057

2.  Unusual uptakes on 18F-fluorocholine positron emission tomography/computed tomography (PET/CT): a retrospective study of 368 prostate cancer patients referred for a biochemical recurrence or an initial staging.

Authors:  Antoine Roland; Clément Drouet; Hatem Boulahdour; Alexandre Cochet; Berardino De Bari
Journal:  Quant Imaging Med Surg       Date:  2021-01

3.  18F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study.

Authors:  Renaud Ciappuccini; Idlir Licaj; Audrey Lasne-Cardon; Emmanuel Babin; Dominique de Raucourt; David Blanchard; Vianney Bastit; Virginie Saguet-Rysanek; Justine Lequesne; Damien Peyronnet; Jean-Michel Grellard; Bénédicte Clarisse; Stéphane Bardet
Journal:  Thyroid       Date:  2020-12-23       Impact factor: 6.568

4.  The role of 18F-FCH PET/CT in patients with uremic hyperparathyroidism compared with 99mTc-sestaMIBI SPECT/CT and ultrasonography.

Authors:  Yu Xue; Wenbo Li; Zhu Xia; Chengming Lei; Yiyi Cao; Zhengjie Wang; Hua Pang
Journal:  EJNMMI Res       Date:  2019-12-26       Impact factor: 3.138

5.  Dedicated Verification of an Accessory Parotid Gland via Minimal-Activity PSMA-PET/CT.

Authors:  Falk Gühne; Robert Drescher; René Aschenbach; Philipp Seifert; Martin Freesmeyer
Journal:  Tomography       Date:  2020-09

6.  Potential Applications of 68Ga-PSMA-11 PET/CT in the Evaluation of Salivary Gland Uptake Function: Preliminary Observations and Comparison with 99mTcO4 - Salivary Gland Scintigraphy.

Authors:  Yanhong Zhao; Yuxiao Xia; Huipan Liu; Zi Wang; Yue Chen; Wei Zhang
Journal:  Contrast Media Mol Imaging       Date:  2020-01-11       Impact factor: 3.161

Review 7.  New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms.

Authors:  Emilia Fortunati; Giulia Argalia; Lucia Zanoni; Stefano Fanti; Valentina Ambrosini
Journal:  Curr Treat Options Oncol       Date:  2022-03-24

Review 8.  PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports.

Authors:  M J M Uijen; Y H W Derks; W A M van Gemert; J Nagarajah; R I J Merkx; M G M Schilham; J Roosen; B M Privé; S A M van Lith; C M L van Herpen; M Gotthardt; S Heskamp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-12       Impact factor: 9.236
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.